A study analysing the efficacy of daclatasvir and asunaprevir treatment for long-term follow up of liver function parameters and liver fibrosis markers in genotype 1b hepatitis C virus infected patients
Latest Information Update: 14 Oct 2016
At a glance
- Drugs Asunaprevir (Primary) ; Daclatasvir (Primary)
- Indications Hepatitis C
- Focus Pharmacodynamics; Therapeutic Use
- 14 Oct 2016 New trial record